Thermo Fisher Scientific Inc (TMO)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 7,337,000 | 6,859,000 | 8,393,000 | 10,028,000 | 7,794,000 |
| Revenue | US$ in thousands | 42,879,000 | 42,857,000 | 44,915,000 | 39,211,000 | 32,218,000 |
| Operating profit margin | 17.11% | 16.00% | 18.69% | 25.57% | 24.19% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $7,337,000K ÷ $42,879,000K
= 17.11%
Thermo Fisher Scientific Inc's operating profit margin has exhibited fluctuations over the past five years. Starting at 24.19% on December 31, 2020, the margin improved to 25.57% by December 31, 2021, indicating strong operational efficiency. However, there was a decline to 18.69% by December 31, 2022, suggesting potential challenges in managing operating expenses relative to revenue generation. This trend continued in the following years with the margin decreasing to 16.00% by December 31, 2023, before recovering slightly to 17.11% by December 31, 2024. Overall, these fluctuations in operating profit margin highlight the company's varying ability to control costs and generate profits from its core operations over the analyzed period.
Peer comparison
Dec 31, 2024